Advanced Search

Cardiovascular Diseases Stocks List

Symbol Grade Name % Change
ABIO F ARCA biopharma, Inc. -3.40
AMRN F Amarin Corporation plc -3.34
GILD D Gilead Sciences, Inc. 0.20
IRWD D Ironwood Pharmaceuticals, Inc. 0.99
NBIX F Neurocrine Biosciences, Inc. -4.14
REGN D Regeneron Pharmaceuticals, Inc. 0.35
XOMA D XOMA Corporation -2.95
BLPH F Bellerophon Therapeutics, Inc. -3.00
CAPR D Capricor Therapeutics, Inc. -3.56
MESO D Mesoblast Limited -4.91
FLGT C Fulgent Genetics, Inc. 2.40
BCDA D BioCardia, Inc. -2.29
VGAC F VG Acquisition Corp. / 23andMe -0.47
QLI F Qilian International Holding Group Ltd. -5.62
View As Page of Charts
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Drug Manufacturers-Specialty & Generic Shell Companies
Related Stock Lists: Cardiovascular Disease Vascular Diseases Biotechnology Biopharmaceutical Heart Failure Medicine Bone Diseases Hypertension Life Sciences Therapeutic Product Therapeutic Products Aging Associated Diseases Anatomy Antibodies Applied Genetics Bone Marrow Cardiac Diseases Cholesterol Clinical Development

Related ETFs - A few ETFs which own one or more of the above listed Cardiovascular Diseases stocks.

Symbol Grade Name Weight
BIS C ProShares UltraShort Nasdaq Biotechnology 13.79
BBH D Market Vectors Biotech ETF 12.53
IBB D iShares Nasdaq Biotechnology Index Fund 11.26
FBT F First Trust Amex Biotech Index Fund 9.96
BIB D ProShares Ultra Nasdaq Biotechnology 8.78
View all Cardiovascular Diseases related ETFs...
Compare ETFs
  • Compare BBH to IBB
  • Compare BIS to BIB
  • Compare BIS to IBB

    • Recent Signals

    Date Stock Signal Type
    2021-03-08 ABIO 180 Bearish Setup Bearish Swing Setup
    2021-03-08 AMRN Fell Below 200 DMA Bearish
    2021-03-08 AMRN Lower Bollinger Band Walk Weakness
    2021-03-08 AMRN 180 Bearish Setup Bearish Swing Setup
    2021-03-08 BLPH 180 Bearish Setup Bearish Swing Setup
    2021-03-08 CAPR Fell Below 200 DMA Bearish
    2021-03-08 FLGT Stochastic Buy Signal Bullish
    2021-03-08 FLGT 50 DMA Resistance Bearish
    2021-03-08 GILD Expansion Pivot Buy Setup Bullish Swing Setup
    2021-03-08 GILD Crossed Above 20 DMA Bullish
    2021-03-08 GILD Pocket Pivot Bullish Swing Setup
    2021-03-08 GILD 200 DMA Resistance Bearish
    2021-03-08 GILD Shooting Star Candlestick Bearish
    2021-03-08 GILD Doji - Bearish? Reversal
    2021-03-08 IRWD 50 DMA Resistance Bearish
    2021-03-08 IRWD 200 DMA Resistance Bearish
    2021-03-08 IRWD Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
    2021-03-08 IRWD Pocket Pivot Bullish Swing Setup
    2021-03-08 MESO 180 Bearish Setup Bearish Swing Setup
    2021-03-08 MESO Lower Bollinger Band Walk Weakness
    2021-03-08 NBIX 180 Bearish Setup Bearish Swing Setup
    2021-03-08 NBIX Lower Bollinger Band Walk Weakness
    2021-03-08 QLI Narrow Range Bar Range Contraction
    2021-03-08 QLI New 52 Week Closing Low Bearish
    2021-03-08 REGN MACD Bullish Signal Line Cross Bullish
    2021-03-08 REGN 20 DMA Resistance Bearish
    2021-03-08 VGAC NR7 Range Contraction
    2021-03-08 VGAC Narrow Range Bar Range Contraction
    2021-03-08 XOMA 180 Bearish Setup Bearish Swing Setup
    2021-03-08 XOMA Slingshot Bearish Bearish Swing Setup

    Recent News for Cardiovascular Diseases Stocks

    Date Stock Title
    Mar 9 MESO Mesoblast Closes US$110/A$138 Million Financing Led by US Strategic Investor Group
    Mar 8 GILD Gilead's (GILD) CAR T Cell Therapy Yescarta Gets FDA Nod for FL
    Mar 8 REGN Why herd immunity is expected later than some may believe
    Mar 8 GILD Gilead announces new four year late-stage data for Biktarvy in HIV
    Mar 8 FLGT FULGENT GENETIC (FLGT) Moves 8% Higher: Will This Strength Last?
    Mar 8 GILD Gilead's Kite Pharma Earns FDA Nod For Yescarta For Type Of Blood Cancer
    Mar 8 REGN An Intrinsic Calculation For Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Suggests It's 30% Undervalued
    Mar 8 GILD Gilead’s Kite Receives FDA Approval For Yescarta Immunotherapy; Street Sees 17% Upside
    Mar 7 REGN Regeneron (REGN) Down 7.5% Since Last Earnings Report: Can It Rebound?
    Mar 7 FLGT Can Fulgent Genetics Stock Rebound?
    Mar 7 GILD Gilead wins FDA approval for Yescarta in follicular lymphoma
    Mar 6 IRWD The Past Week's Most Notable Insider Buys: Editas, Exxon Mobil, Wayfare And More
    Mar 6 GILD Why Is Gilead (GILD) Down 1.8% Since Last Earnings Report?
    Mar 6 CAPR The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings
    Mar 6 GILD After 2 Licensing Deals Will GlaxoSmithKline Acquire Vir?
    Mar 6 GILD Biktarvy® Demonstrates High Efficacy and Durable Viral Suppression in Treatment-Naïve Adults in Four-Year Data Presented at CROI
    Mar 6 GILD U.S. FDA Approves Yescarta® for Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy
    Mar 5 GILD Money worries are holding people back from getting the vaccine
    Mar 5 REGN Money worries are holding people back from getting the vaccine
    Mar 5 REGN Doctor: ‘We may be reaching that critical point of herd immunity’
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Drug Manufacturers-Specialty & Generic Shell Companies
    Related Stock Lists: Cardiovascular Disease Vascular Diseases Biotechnology Biopharmaceutical Heart Failure Medicine Bone Diseases Hypertension Life Sciences Therapeutic Product Therapeutic Products Aging Associated Diseases Anatomy Antibodies Applied Genetics Bone Marrow Cardiac Diseases Cholesterol Clinical Development

    Browse All Tags